Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTA vs EBRRM for Full Pulpotomy in Irreversible Pulpitis
NCT05853185Phase 4Completed
- Sponsor
- Liaquat University of Medical and Health Sciences
- Start
- Oct 2021
- Primary completion
- May 2022
- Countries
- 1
01
Overview
Phase 4, randomised trial in irreversible pulpitis, sponsored by Liaquat University of Medical and Health Sciences. Primary endpoint: Clinical Success at 6 Months. Started Oct 2021; status: completed.
02
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT05853185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05853185.